scholarly journals Dietary Patterns of Patients with Chronic Kidney Disease: The Influence of Treatment Modality

Nutrients ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 1920 ◽  
Author(s):  
Fernanda Santin ◽  
Daniela Canella ◽  
Camila Borges ◽  
Bengt Lindholm ◽  
Carla Avesani
Keyword(s):  
Chronic Kidney Disease ◽  
Food Intake ◽  
Renal Transplant ◽  
Kidney Disease ◽  
Dietary Patterns ◽  
Treatment Modality ◽  
National Health Survey ◽  
Alcoholic Beverages ◽  
Linear Regression Models ◽  
Treatment Groups

Background: We analyzed the dietary patterns of Brazilian individuals with a self-declared diagnosis of chronic kidney disease (CKD) and explored associations with treatment modality. Methods: Weekly consumption of 14 food intake markers was analyzed in 839 individuals from the 2013 Brazil National Health Survey with a self-declared diagnosis of CKD undergoing nondialysis (n = 480), dialysis (n = 48), or renal transplant (n = 17) treatment or no CKD treatment (n = 294). Dietary patterns were derived by exploratory factor analysis of food intake groups. Multiple linear regression models, adjusted by sociodemographic and geographical variables, were used to evaluate possible differences in dietary pattern scores between different CKD treatment groups. Results: Two food patterns were identified: an “Unhealthy” pattern (red meat, sweet sugar beverages, alcoholic beverages, and sweets and a negative loading of chicken, excessive salt, and fish) and a “Healthy” pattern (raw and cooked vegetables, fruits, fresh fruit juice, and milk). The Unhealthy pattern was inversely associated with nondialysis and dialysis treatment (β: −0.20 (95% CI: −0.33; −0.06) and β: −0.80 (−1.16; −0.45), respectively) and the Healthy pattern was positively associated with renal transplant treatment (β: 0.32 (0.03; 0.62)). Conclusions: Two dietary patterns were identified in Brazilian CKD individuals and these patterns were linked to CKD treatment modality.

Relevance of Chronic Kidney Disease Classification (K/DOQI) in Renal Transplant Patients

2006 ◽  
Vol 38 (8) ◽  
pp. 2402-2403 ◽  
Author(s):  
G. Fernandez-Fresnedo ◽  
A. de Francisco ◽  
J.C. Ruiz ◽  
J.G. Cotorruelo ◽  
C.G. Alamillo ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Transplant ◽  
Kidney Disease ◽  
Disease Classification ◽  
Transplant Patients ◽  
Renal Transplant Patients

scholarly journals Progression of Aortic Calcification in Stage 4–5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation

2021 ◽  
pp. 1-8
Author(s):  
Roosa Lankinen ◽  
Markus Hakamäki ◽  
Tapio Hellman ◽  
Niina S. Koivuviita ◽  
Kaj Metsärinne ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Conservative Treatment ◽  
Left Ventricular ◽  
Waiting List ◽  
Aortic Calcification ◽  
Transplant Recipients ◽  
Treatment Groups ◽  
In The Beginning

<b><i>Background and Aims:</i></b> Abdominal aortic calcification (AAC) is common in chronic kidney disease (CKD) patients and associated with increased mortality. Comparative data on the AAC score progression in CKD patients transitioning from conservative treatment to different modalities of renal replacement therapy (RRT) are lacking and were examined. <b><i>Methods:</i></b> 150 study patients underwent lateral lumbar radiograph to study AAC in the beginning of the study before commencing RRT (AAC1) and at 3 years of follow-up (AAC2). We examined the associations between repeated laboratory tests taken every 3 months, echocardiographic and clinical variables and AAC increment per year (ΔAAC), and the association between ΔAAC and outcomes during follow-up. <b><i>Results:</i></b> At the time of AAC2 measurement, 39 patients were on hemodialysis, 39 on peritoneal dialysis, 39 had a transplant, and 33 were on conservative treatment. Median AAC1 was 4.8 (0.5–9.0) and median AAC2 8.0 (1.5–12.0) (<i>p</i> &#x3c; 0.0001). ΔAAC was similar across the treatment groups (<i>p</i> = 0.19). ΔAAC was independently associated with mean left ventricular mass index (LVMI) (log LVMI: β = 0.97, <i>p</i> = 0.02) and mean phosphorus through follow-up (log phosphorus: β = 1.19, <i>p</i> = 0.02) in the multivariable model. Time to transplantation was associated with ΔAAC in transplant recipients (per month on the waiting list: β = 0.04, <i>p</i> = 0.001). ΔAAC was associated with mortality (HR 1.427, 95% confidence interval 1.044–1.950, <i>p</i> = 0.03). <b><i>Conclusion:</i></b> AAC progresses rapidly in patients with CKD, and ΔAAC is similar across the CKD treatment groups including transplant recipients. The increment rate is associated with mortality and in transplant recipients with the time on the transplant waiting list.

Longitudinal assessment of bone quality in pediatric patients with chronic kidney disease in relation to treatment modality

2014 ◽  
Vol 33 (3) ◽  
pp. 303-310 ◽  
Author(s):  
Chrysa Gkogka ◽  
Athanasios Christoforidis ◽  
Nikoleta Printza ◽  
Konstantinos Kollios ◽  
Eirini Kazantzidou ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Bone Quality ◽  
Treatment Modality ◽  
Pediatric Patients ◽  
Longitudinal Assessment

The Efficacy of Adipose-Derived Stem Cells (ADSCs) on Chronic Kidney Disease in Dogs

2019 ◽  
Vol 11 (12) ◽  
pp. 1724-1728
Author(s):  
Mengling Zhu ◽  
Xiaoyun Lai ◽  
Yixin Wen ◽  
Haibin Zhang
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Function ◽  
Treatment Group ◽  
Kidney Disease ◽  
Adipose Derived Stem Cells ◽  
Tubular Epithelial Cells ◽  
Renal Tubular Epithelial Cells ◽  
Urine Protein ◽  
Treatment Groups ◽  
Renal Tubular

To investigate the therapeutic effect of adipose-derived stem cells (ADSCs) on chronic kidney disease (CKD) in dogs, blood routine examination, urine protein quantitative test, renal function test, urine sediment staining microscopy and B-ultrasonic test of kidney were used to compare the treatment of chronic kidney disease in dogs treated with three different therapies (NT treatment group: traditional supportive therapy group; MT1 treatment group: ADSCs treatment group; MT2 treatment group: NT mixed MT1 treatment group). Results showed that the numbers of red blood cells (RBC), hemoglobin (HGB) and hematocrit (HCT) in MT1 and MT2 treatment groups were higher than those in the NT group, and the urine protein excretion and the levels of serum urea and creatinine in MT1 and MT2 treatment groups were lower than those in the NT treatment group. Besides, there was no further deterioration of kidney morphology in MT1 and MT2 treatment groups. However, a large number of renal tubular epithelial cells and epithelial casts were observed in NT treatment group, while only a small number of renal tubular epithelial cells were observed in MT1 and MT2 treatment groups, indicating the intravenous injection of ADSCs can significantly improve the physical signs and renal function of dogs with CKD, and combined with the traditional therapy, ADSCs has a good prospect for the treatment of CKD in dogs.

Sign in / Sign up

Export Citation Format

Share Document